相关实验视频
Updated: Jul 27, 2025

10:42
A Tripeptide-Stabilized Nanoemulsion of Oleic Acid
Published on: February 27, 2019
9.4K
治疗性的长效输送配方的最新进展
Parham Sahandi Zangabad1,2, Zahra Abousalman Rezvani1,3, Ziqiu Tong1
1Drug Delivery, Disposition and Dynamics, Monash Institute of Pharmaceutics Science, Monash University, Parkville Campus, Parkville, Victoria 3052, Australia.
ACS applied bio materials
|June 9, 2023
概括
治疗性提供强效的疾病治疗方法,但面临的交付挑战. 像纳米颗粒和水凝这样的创新配方增强了的输送,提高了持续释放的疗效和患者遵守性.
科学领域:
- 制药科学 制药科学
- 生物技术是生物技术.
- 药物运输 药物运输 药物运输
背景情况:
- 治疗性显示出对各种疾病的高强度和特异性.
- 挑战包括口服生物可用性差,半衰期短和降解.
- 目前的治疗方法需要高剂量和频繁的使用.
研究的目的:
- 审查治疗性和它们的输送挑战.
- 探索递送配方的最新进展.
- 讨论这些配方对的生物活性和释放的影响.
主要方法:
- 对治疗性的临床前和临床研究的综述.
- 探索各种递送系统:微/纳米粒子,水凝,复合材料和支架.
- 对配方对负载,生物活性和释放动力学的影响分析.
主要成果:
- 制药配方显著改善治疗性的管理.
- 创新包括长效的输送,精确的剂量和增强的患者遵守.
- 在先进的传送系统中使用了各种材料 (脂质,聚合物,,刺激反应).
结论:
- 先进的配方克服了治疗性递送的关键限制.
- 这些系统可实现长期和持续的释放,优化处理.
- 未来的研究重点是提高的生物活性和受控释放参数.
相关概念视频
Insulin Formulations: Types and Delivery
238
Insulin preparations are categorized by their duration of action into short-acting and long-acting types. Two strategies are used to modify insulin's absorption and pharmacokinetic profile: slowing the absorption post-subcutaneous injection, or altering human insulin's amino acid sequence or protein structure. These changes retain the insulin's ability to bind to the insulin receptor, but alter its behavior in solution or after injection.
Short-acting insulins are divided into...
Short-acting insulins are divided into...
238
Biopharmaceutics and Pharmacokinetics: Overview
2.2K
Understanding drugs, drug products, and their performance in pharmaceutical science is pivotal. Drugs, whether simple molecules or complex compounds, are designed to interact with the body's biological systems to diagnose, treat, or prevent diseases. Drug products include various delivery systems such as tablets, capsules, injections, and inhalers. The performance of these drug products is gauged by their ability to deliver the active ingredient to the desired site of action at the...
2.2K
Drug Delivery: Miscellaneous Routes
408
Drug delivery methods like oral inhalation, nasal sprays, transdermal patches, eye drops, intravitreal injection, and rectal administration provide localized effects with reduced toxicity.
Oral inhalation and nasal sprays swiftly transfer drugs across the respiratory epithelium's mucosal layer. Inhaled glucocorticoids and bronchodilators directly target lung conditions such as asthma, while fluticasone nasal spray mitigates allergic rhinitis.
Transdermal patches transport drugs...
Oral inhalation and nasal sprays swiftly transfer drugs across the respiratory epithelium's mucosal layer. Inhaled glucocorticoids and bronchodilators directly target lung conditions such as asthma, while fluticasone nasal spray mitigates allergic rhinitis.
Transdermal patches transport drugs...
408
Drug Delivery: Overview
329
The selection of a drug's delivery route depends upon its physicochemical properties, including lipid or water solubility and ionization, as well as the therapeutic requirement, such as immediate or sustained effect. These routes can be divided into three primary categories: enteral, parenteral, and topical.
Enteral delivery involves administering drugs directly through swallowing, sublingual placement, or buccal application. Orally administered drugs predominantly navigate the...
Enteral delivery involves administering drugs directly through swallowing, sublingual placement, or buccal application. Orally administered drugs predominantly navigate the...
329
Drug Delivery: Parenteral Route
645
The parenteral route is a critical method of drug administration. It delivers compounds directly into the systemic circulation and bypasses the gastrointestinal tract. This approach is particularly advantageous for drugs that exhibit poor absorption or instability when administered orally.
There are three primary parenteral routes: intravenous (IV), intramuscular (IM), and subcutaneous (SC). The IV route introduces the drug directly into the bloodstream, ensuring immediate action. The IM route...
There are three primary parenteral routes: intravenous (IV), intramuscular (IM), and subcutaneous (SC). The IV route introduces the drug directly into the bloodstream, ensuring immediate action. The IM route...
645
Glucagon-like Receptor Agonists
370
Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
370

